Skip to Content
Notice

Notice of Intent To Grant a Partially Exclusive Patent License; Oasis Diagnostics Corp

Action

Notice.

Summary

The Department of the Navy hereby gives notice of its intent to grant to Oasis Diagnostics Corp., a revocable, nonassignable, partially exclusive license to practice worldwide the Government owned inventions described in U.S. Patent No. 6,841,159 issued on January 11, 2005, for “Rapid Lateral Flow Assay for Determining Exposure to Mycobacterium Tuberculosis and other mycobacteria”; and related foreign filings (PCT/US 03/02311, EP/1478395, and AU/2003210662 filed) in the fields of detection of antibodies in present in oral fluids from the group saliva, oral rinse expectorant, oral mucosal transudate, gingival crevicular fluid, and phlegmuntil.

 

Table of Contents Back to Top

DATES: Back to Top

Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than November 13, 2007.

ADDRESSES: Back to Top

Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Back to Top

Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500, telephone: 301-319-7428.

Dated: October 23, 2007.

T.M. Cruz,

Lieutenant,Judge Advocate General's Corps,U.S. Navy,Federal Register Liaison Officer.

[FR Doc. E7-21202 Filed 10-26-07; 8:45 am]

BILLING CODE 3810-FF-P

Site Feedback